 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 04/18/2024 |
$0.98 |
$1.04 |
$0.77 |
$0.81 |
6.38M | | 04/19/2024 |
$0.81 |
$0.82 |
$0.72 |
$0.75 |
1.68M | | 04/22/2024 |
$0.74 |
$0.75 |
$0.70 |
$0.73 |
1.31M | | 04/23/2024 |
$0.74 |
$0.80 |
$0.73 |
$0.77 |
676.10K | | 04/24/2024 |
$0.77 |
$0.77 |
$0.70 |
$0.72 |
877.80K |
|
|
| Citius Pharmaceuticals is a pharmaceutical company. Co. is developing the following products: Mino-Lok, an antibiotic lock solution used to treat patients with catheter-related bloodstream infections; Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries; Halo-Lido, a corticosteroid-lidocaine topical formulation that provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids; NoveCite, a mesenchymal stem cell therapy for the treatment of acute respiratory disease syndrome; and I/ONTAK, a IL-2 diphtheria toxin fusion protein for the treatment of patients with recurrent cutaneous T-cell lymphoma. | |
|
Citius Pharmaceuticals (CTXR) has the following price history information. Looking back at CTXR historical stock prices for the last five trading days, on April 18, 2024, CTXR opened at $0.98, traded as high as $1.04 and as low as $0.77, and closed at $0.81. Trading volume was a total of 6.38M shares. On April 19, 2024, CTXR opened at $0.81, traded as high as $0.82 and as low as $0.72, and closed at $0.75. Trading volume was a total of 1.68M shares. On April 22, 2024, CTXR opened at $0.74, traded as high as $0.75 and as low as $0.70, and closed at $0.73. Trading volume was a total of 1.31M shares. On April 23, 2024, CTXR opened at $0.74, traded as high as $0.80 and as low as $0.73, and closed at $0.77. Trading volume was a total of 676.10K shares. On April 24, 2024, CTXR opened at $0.77, traded as high as $0.77 and as low as $0.70, and closed at $0.72. Trading volume was a total of 877.80K shares.
CTXR Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Citius Pharmaceuticals shares, starting with a $10,000 purchase of CTXR, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
06/13/2017 |
|
| End date: |
04/24/2024 |
|
| Start price/share: |
$6.60 |
|
| End price/share: |
$0.72 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-89.14% |
|
| Average Annual Total Return: |
-27.62% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$1,085.90 |
|
| Years: |
6.87 |
|
|
|
| Date |
Close |
| 04/18/2024 | $0.81 | | 04/19/2024 | $0.75 | | 04/22/2024 | $0.73 | | 04/23/2024 | $0.77 | | 04/24/2024 | $0.72 |
|
|
Free CTXR Email Alerts:
